Table 1 The antibodies used in this study and their results

EMA

E29

DakoCytomation (Carpinteria, CA, USA)

+

+

⁺⁺

GCDFP-15

NCL-GCDFP15

Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK)

-

-

-

Her-2

DakoCytomation (Carpinteria CA)

-

1+

3+

EGFR

NCL-L-EGFR

Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK)

-

-

-

AR

AR441

DakoCytomation (Carpinteria, CA, USA)

-

-

-

CK5/6

D5/16 B4

DakoCytomation (Carpinteria, CA, USA)

+

+

-(myo+)

S-100

DakoCytomation (Carpinteria, CA, USA)

+

+

-

ASMA

1A4

DakoCytomation (Carpinteria, CA, USA)

++

+

-

calponin

CALP

DakoCytomation (Carpinteria, CA, USA)

+

f+

-

CK14

LL002

Chemicon International (Temecula, CA, USA)

+

p+

-(myo+)

p63

4A4

Lab Vision (Fremont, CA, USA)

++

p+

-(myo+)

mammaglobin

304-1A5

DakoCytomation (Carpinteria, CA, USA)

-

f+

p53

DO-7

DakoCytomation (Carpinteria, CA, USA)

f+

p+

++

cyclin A

NCL-CYCLN A

Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK)

10.3%

17.3%

34.5%

cyclin B1

NCL-CYCLN B1

Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK)

0.5%

12.2%

50.3%

cyclin D1

DSC-6

DakoCytomation (Carpinteria CA, USA)

-

1.1%

-

cylcin E

NCL-CYCLN E

Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK)

-

-

-

p16

G175-405

BD Biosciences (Franklin Lakes, NJ, USA)

f+

p+

++

MDM2

SMP14

Themo Fisher Scientific (Cheshire, UK)

-

-

-

Ki-67L.I.

MIB-1

DakoCytomation (Carpinteria, CA, USA)

34.5%

49.7%

73.2%